urea has been researched along with prostaglandin d2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelrahman, M; Collin, M; Thiemermann, C | 1 |
| Czechowska, G; Dudka, J; Korolczuk, A; Maciejewski, M; Smolen, A; Widelska, I | 1 |
| Feng, J; Gao, X; Li, J; Li, W; Li, Z; Lu, M; Meng, P; Zhang, Y | 1 |
3 other study(ies) available for urea and prostaglandin d2
| Article | Year |
|---|---|
The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatinine; Intestine, Small; Kidney; Lung; Male; Peroxisome Proliferator-Activated Receptors; Prostaglandin D2; Rats; Rats, Wistar; Shock, Hemorrhagic; Urea | 2004 |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Topics: Animals; Creatinine; Cyclosporine; Disease Models, Animal; Glutathione; Glutathione Disulfide; Kidney; Kidney Diseases; Male; NAD; NADP; PPAR gamma; Prostaglandin D2; Protective Agents; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Urea; Uric Acid | 2014 |
PPARĪ³ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
Topics: Animals; Cell Proliferation; Creatinine; Dialysis Solutions; Glucose; Glucose Transporter Type 1; Nitrogen; Peritoneal Fibrosis; PPAR gamma; Prostaglandin D2; Rats; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta; Urea | 2022 |